Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Brenk

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Anticancer Research|April 12, 2015
Quantitative structure-activity relationship and molecular docking of artemisinin derivatives to vascular endothelial growth factor receptor 1Mohamed E M Saeed, Onat Kadioglu, Ean-Jeong Seo, et al.
Biomolecules|February 21, 2020
Targeting the Class A Carbapenemase GES-5 via Virtual ScreeningRaphael Klein, Laura Cendron, Martina Montanari, et al.
Plos One|May 8, 2012
IspE inhibitors identified by a combination of in silico and in vitro high-throughput screeningNaomi Tidten-Luksch, Raffaella Grimaldi, Leah S Torrie, et al.
Chemmedchem|December 8, 2007
Lessons learnt from assembling screening libraries for drug discovery for neglected diseasesRuth Brenk, Alessandro Schipani, Daniel James, et al.
Nature Chemistry|May 22, 2010
Nucleophilic catalysis of acylhydrazone equilibration for protein-directed dynamic covalent chemistryVenugopal T Bhat, Anne M Caniard, Torsten Luksch, et al.
European Journal of Medicinal Chemistry|April 15, 2025
Towards new antibiotics: P. aeruginosa FabF ligands discovered by crystallographic fragment screening followed by hit expansionCharis Georgiou, Ludvik Olai Espeland, Hemalatha Bukya, et al.
Acta Crystallographica. Section F, Structural Biology Communications|August 8, 2015
Structures of Pseudomonas aeruginosa β-ketoacyl-(acyl-carrier-protein) synthase II (FabF) and a C164Q mutant provide templates for antibacterial drug discovery and identify a buried potassium ion and a ligand-binding site that is an artefact of the crystal formBernhard Baum, Laura S M Lecker, Martin Zoltner, et al.
Journal of Molecular Biology|March 31, 2004
Crystallographic study of inhibitors of tRNA-guanine transglycosylase suggests a new structure-based pharmacophore for virtual screeningRuth Brenk, Emmanuel A Meyer, Klaus Reuter, et al.
Frontiers in Cell and Developmental Biology|July 3, 2023
RNA-binding is an ancient trait of the Annexin familySudarshan S Patil, Vipul Panchal, Trude Røstbø, et al.
Plos One|May 9, 2019
Identification of a potential allosteric site of Golgi α-mannosidase II using computer-aided drug designLina Irsheid, Thomas Wehler, Christoph Borek, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Anticancer Research|April 12, 2015
Quantitative structure-activity relationship and molecular docking of artemisinin derivatives to vascular endothelial growth factor receptor 1Mohamed E M Saeed, Onat Kadioglu, Ean-Jeong Seo, et al.
Biomolecules|February 21, 2020
Targeting the Class A Carbapenemase GES-5 via Virtual ScreeningRaphael Klein, Laura Cendron, Martina Montanari, et al.
Plos One|May 8, 2012
IspE inhibitors identified by a combination of in silico and in vitro high-throughput screeningNaomi Tidten-Luksch, Raffaella Grimaldi, Leah S Torrie, et al.
Chemmedchem|December 8, 2007
Lessons learnt from assembling screening libraries for drug discovery for neglected diseasesRuth Brenk, Alessandro Schipani, Daniel James, et al.
Nature Chemistry|May 22, 2010
Nucleophilic catalysis of acylhydrazone equilibration for protein-directed dynamic covalent chemistryVenugopal T Bhat, Anne M Caniard, Torsten Luksch, et al.
European Journal of Medicinal Chemistry|April 15, 2025
Towards new antibiotics: P. aeruginosa FabF ligands discovered by crystallographic fragment screening followed by hit expansionCharis Georgiou, Ludvik Olai Espeland, Hemalatha Bukya, et al.
Acta Crystallographica. Section F, Structural Biology Communications|August 8, 2015
Structures of Pseudomonas aeruginosa β-ketoacyl-(acyl-carrier-protein) synthase II (FabF) and a C164Q mutant provide templates for antibacterial drug discovery and identify a buried potassium ion and a ligand-binding site that is an artefact of the crystal formBernhard Baum, Laura S M Lecker, Martin Zoltner, et al.
Journal of Molecular Biology|March 31, 2004
Crystallographic study of inhibitors of tRNA-guanine transglycosylase suggests a new structure-based pharmacophore for virtual screeningRuth Brenk, Emmanuel A Meyer, Klaus Reuter, et al.
Frontiers in Cell and Developmental Biology|July 3, 2023
RNA-binding is an ancient trait of the Annexin familySudarshan S Patil, Vipul Panchal, Trude Røstbø, et al.
Plos One|May 9, 2019
Identification of a potential allosteric site of Golgi α-mannosidase II using computer-aided drug designLina Irsheid, Thomas Wehler, Christoph Borek, et al.
Pageof 7